Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2955-2962

  Gultekin, Melis ^a   Yildiz, Ferah ^a   Ozyigit, Gokhan ^a   Beyaz, Havva ^a   Hayran, Mutlu ^a   Kose, Faruk ^b   Yuce, Kunter ^a   Ayhan, Ali ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Etlik Zubeyde Hanim Maternity and Women's Health Teaching and Research Hospital   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

Endometrial carcinoma; FIGO; Prognosis; Staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VAGINAL CUFF BRACHYTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS;

EID: 84867990027     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0196-x     Document Type: Article

References (27)

1. Cancer Committee Report to the General Assembly of FIGO. Classification and staging of malignant tumor in the female pelvis. Int J Gynaecol Obstet: The official organ of the international federation of gynaecology and obstetrics. 1971;9:172-9.
2. FIGO stages-1988 revision. Gynecol Oncol. 1989;35:125-127.
3. Mariani A, Webb M, Keeney G, et al. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38-44.
4. Tebeu PM, Popowski Y, Verkooijen HM, et al. Positive peritoneal cytology in early stage endometrial cancer does not influence prognosis. Br J Cancer. 2004;16:720-4.
5. Nelson G, Randall M, Sutton G, et al. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol. 1999;75:211-4.
6. Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol. 2009;28:1-9.
7. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
8. Atahan IL, Ozyar E, Yildiz F, et al. Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery. Int J Gynecol Cancer. 2008;18:1294-9.
9. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
10. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 1990;38:99-104.
11. Gatta G, Lasota M, Verfecchia A. Working Group. Survival of European women with gynaecological tumours during the period 1978-89. Eur J Cancer. 1998;34:2218-25.
12. Lewin SN, Herzog TJ, Barrena Medel NI, et al. Comparative performance of the 2009. International federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2010;116:1141-9.
13. Cooke EW, Pappas L, Gaffney DK. Does the revised international federation of gynecology and obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer. 2011;117:4231-7.
14. Werner HMJ, Trovik J, Marcickiewicz J et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Gynecol Oncol;2011, doi: 10.1016/j.ygyno.2011.11.008.
15. Abu-Rustum NR, Zhou Q, Iasonos A, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2011;21:511-6.
16. Jordan LB, Al-Nafussi A. Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma. Int J Gynecol Cancer. 2002;12:42-8.
17. Ayhan A, Taskiran C, Celik C, et al. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol. 2004;93:9-13.
18. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-75.
19. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol. 2000;76:348-56.
20. Solhjem MC, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:1379-84.
21. Horowitz NS, Peters WA III, Smith MR, et al. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol. 2002;99:235-40.
22. Mariani A, Keeney GL, Aletti G, et al. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol. 2004;92:833-8.
23. McMeekin DS, Lashbrook D, Gold M, et al. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol. 2001;81:273-8.
24. ASTEC study group, Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomised study. Lancet. 2009;373:125-36.
25. Connell PP, Rotmensch J, Waggoner S, Mundt AJ. The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol. 1999;74:74-9.
26. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404-11.
27. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol. 2004;22:1234-41.